Ear Drops Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Ear Drops Market is anticipated to grow at a significant CAGR during the forecast period. Ear drops are a liquid medicine that is used to treat or prevent ear infections of the outer ear and ear canal (otitis externa). It also supports remove ear wax as well as for short-term treatment and are easily available over-the-counter or with a prescription. The major factor for the growth of the market is the increasing prevalence of ear infections.

According to the World Health Organization (WHO), ear infections are the leading cause of hearing loss. As per the WHO estimates, nearly 2.5 billion people are anticipated to have some degree of hearing loss and at least 700 million will require hearing rehabilitation by 2050. Furthermore, new product launches are also boosting the growth of the global ear drops market during the forecast period. For instance, in August 2020, Dr Reddy's Laboratories announced the launch of a generic version of Ciprodex that is used to treat ear infections in the US market. The newly launched product is equivalent to the generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension.

Some major players in the market include Daiichi Sankyo Co., Ltd, Sanofi S.A., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2020, Sandoz Inc. (Novartis International AG) announced the launch of Ciprofloxacin 0.3% + Dexamethasone 0.1% otic suspension 7.5mL ear drops in the US market. It is used to treat middle ear and outer ear canal bacterial infections.

To Request a Sample of our Report on Ear Drops Market: https://www.omrglobal.com/request-sample/ear-drops-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2023-2030

Segment Covered-

· By Product Type

· By Application

Regions Covered-

· • North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Daiichi Sankyo Co., Ltd, Sanofi S.A., and Novartis International AG, among others.

Ear Drops Market Report by Segment

· By Product Type

· Ciprodex Ear Drop

· Gentisone HC Ear Drop

· Ciproxin HC Ear Drop

By Application

· Adults

· Children

· Elderly

A full Report of Ear Drops Market is Available @ https://www.omrglobal.com/industry-reports/ear-drops-market

Ear Drops Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

• Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ear-drops-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.